{"id":"W2091567174","doi":"10.1586/14737140.2015.1014343","title":"Dabrafenib in the treatment of metastatic or unresectable melanoma","year":2015,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Melanoma; Metastatic melanoma; Oncology; Vemurafenib; Internal medicine; Clinical trial; Immunotherapy; Progression-free survival; Overall survival; Cancer research; Cancer; MAPK/ERK pathway; Kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004198049,0.0006559757,0.001012554,0.00170207,0.0001969993,0.0006601294,0.0006345314,0.0006939479,0.004131613],"category_scores_gemma":[0.0003551108,0.0001939265,0.0004465226,0.001524918,0.0002663544,0.0008368595,0.0006287025,0.001463581,0.002308932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004136265,"about_ca_system_score_gemma":0.000626836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007101515,"about_ca_topic_score_gemma":0.002009078,"domain_scores_codex":[0.9998817,0.00002144647,0.00001566472,0.00002056273,0.00004707134,0.00001353773],"domain_scores_gemma":[0.9998848,0.00004123663,0.00002245861,0.000003187357,0.00003145226,0.00001686604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007831876,0.00005501277,0.00009867766,0.01229691,0.0000872222,0.0001806683,0.0000315532,0.000340368,0.001547115,0.001933576,0.03402269,0.9493279],"study_design_scores_gemma":[0.00002845916,0.00009538468,0.0005473615,0.00232763,0.00009940615,0.001416595,0.00003022063,0.00009311228,0.0003678529,0.001471741,0.9935082,0.00001392336],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001008858,0.9986759,0.00007960566,0.0001910915,0.0001329524,0.000003349321,0.00001363817,0.000005588991,0.000797038],"genre_scores_gemma":[0.0006894777,0.9983735,0.00008654921,0.0001482892,0.0001020374,0.000003414825,0.00002741056,0.000001066854,0.0005682287],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004131613,"threshold_uncertainty_score":0.0138216,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1136130243722451,"score_gpt":0.4255522667774826,"score_spread":0.3119392424052375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}